E2F2
Transcription factor E2F2
Also known as: E2F-2, E2F2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14209
- Gene
- E2F2
- Ensembl
- ENSG00000007968
- Chromosome
- 1
- Canonical length
- 437 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F1 and E2F3, have an additional cyclin binding domain. This protein binds specifically to retinoblastoma protein pRB in a cell-cycle dependent manner, and it exhibits overall 46% amino acid identity to E2F1. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
437 residues, UniProt reviewed canonical sequence.
>Q14209|E2F2
1 MLQGPRALAS AAGQTPKVVP AMSPTELWPS GLSSPQLCPA TATYYTPLYP QTAPPAAAPG
61 TCLDATPHGP EGQVVRCLPA GRLPAKRKLD LEGIGRPVVP EFPTPKGKCI RVDGLPSPKT
121 PKSPGEKTRY DTSLGLLTKK FIYLLSESED GVLDLNWAAE VLDVQKRRIY DITNVLEGIQ
181 LIRKKAKNNI QWVGRGMFED PTRPGKQQQL GQELKELMNT EQALDQLIQS CSLSFKHLTE
241 DKANKRLAYV TYQDIRAVGN FKEQTVIAVK APPQTRLEVP DRTEDNLQIY LKSTQGPIEV
301 YLCPEEVQEP DSPSEEPLPS TSTLCPSPDS AQPSSSTDPS IMEPTASSVP APAPTPQQAP
361 PPPSLVPLEA TDSLLELPHP LLQQTEDQFL SPTLACSSPL ISFSPSLDQD DYLWGLEAGE
421 GISDLFDSYD LGDLLINLocalizationUniProt · AlphaFold · HPA
Whether an antibody against E2F2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 24 nTPM
- thymus: 15 nTPM
- esophagus: 8.3 nTPM
- spleen: 4.8 nTPM
- testis: 3.4 nTPM
- tonsil: 3.4 nTPM
Single-cell type
- late spermatids: 33 nCPM
- early spermatids: 5.4 nCPM
- erythrocytes: 2.2 nCPM
- erythrocyte progenitors: 0.8 nCPM
- late primary spermatocytes: 0.8 nCPM
- monocyte progenitors: 0.6 nCPM
Immune cell
- basophil: 4.1 nTPM
- T-reg: 1.3 nTPM
- non-classical monocyte: 0.9 nTPM
- eosinophil: 0.8 nTPM
- intermediate monocyte: 0.6 nTPM
- myeloid DC: 0.5 nTPM
Brain region
- thalamus: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- choroid plexus: 0.5 nTPM
- pons: 0.5 nTPM
- white matter: 0.5 nTPM
- amygdala: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.26
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intrinsic apoptotic signaling pathway by p53 class mediator
- lens fiber cell apoptotic process
- negative regulation of sprouting angiogenesis
- positive regulation of transcription by RNA polymerase II
- regulation of cell cycle
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- transcription initiation at RNA polymerase II promoter
Molecular functions
- cis-regulatory region sequence-specific DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of E2F2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads E2F2 as an antibody target. Whether an autoantibody or antibody against E2F2 could matter depends on whether native E2F2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
E2F2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label E2F2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...